The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Journal Article

   

Authors:	Alaggio, R.; Amador, C.; Anagnostopoulos, I.; Attygalle, A. D.; de Oliveira Araujo, I. B.; Berti, E.; Bhagat, G.; Borges, A. M.; Boyer, D.; Calaminici, M.; Chadburn, A.; Chan, J. K. C.; Cheuk, W.; Chng, W. J.; Choi, J. K.; Chuang, S. S.; Coupland, S. E.; Czader, M.; Dave, S. S.; de Jong, D.; Du, M. Q.; Elenitoba-Johnson, K. S.; Ferry, J.; Geyer, J.; Gratzinger, D.; Guitart, J.; Gujral, S.; Harris, M.; Harrison, C. J.; Hartmann, S.; Hochhaus, A.; Jansen, P. M.; Karube, K.; Kempf, W.; Khoury, J.; Kimura, H.; Klapper, W.; Kovach, A. E.; Kumar, S.; Lazar, A. J.; Lazzi, S.; Leoncini, L.; Leung, N.; Leventaki, V.; Li, X. Q.; Lim, M. S.; Liu, W. P.; Louissaint, A. Jr; Marcogliese, A.; Medeiros, L. J.; Michal, M.; Miranda, R. N.; Mitteldorf, C.; Montes-Moreno, S.; Morice, W.; Nardi, V.; Naresh, K. N.; Natkunam, Y.; Ng, S. B.; Oschlies, I.; Ott, G.; Parrens, M.; Pulitzer, M.; Rajkumar, S. V.; Rawstron, A. C.; Rech, K.; Rosenwald, A.; Said, J.; Sarkozy, C.; Sayed, S.; Saygin, C.; Schuh, A.; Sewell, W.; Siebert, R.; Sohani, A. R.; Tooze, R.; Traverse-Glehen, A.; Vega, F.; Vergier, B.; Wechalekar, A. D.; Wood, B.; Xerri, L.; Xiao, W.
Article Title:	The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Abstract:	We herein present an overview of the upcoming 5(th) edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4(th) edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5(th) edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Keywords:	chronic; disease; acute lymphoblastic-leukemia; clinicopathological features; genetic alterations; lymphocytic-leukemia; lymphoproliferative; multicentric; lymphoplasmacytic lymphoma; predominant hodgkin lymphoma; castleman disease; t-cell-lymphoma; diffuse follicular lymphoma
Journal Title:	Leukemia
Volume:	36
Issue:	7
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Date Published:	2022-07-01
Start Page:	1720
End Page:	1748
Language:	English
ACCESSION:	WOS:000814462100003
DOI:	10.1038/s41375-022-01620-2
PROVIDER:	wos
PMCID:	PMC9214472
PUBMED:	35732829
Notes:	Review -- Erratum issued, see DOI: 10.1038/s41375-023-01962-5 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/196643